Catalyzing Affordable Healthcare: The 22 Coalition, Cyient, and India2022 – A Collaborative Approach to Diagnostics
Access to timely and accurate medical diagnostics is a cornerstone of effective healthcare. However, for many, especially in emerging economies, affordability and accessibility remain important barriers. A powerful collaboration is underway to address this challenge: the 22 Coalition,spearheaded by Cyient and powered by the India2022 initiative. This article delves into the mission, partners, and potential impact of this vital effort.
The 22 Coalition: Bridging the Diagnostic Gap
The 22 Coalition is a dynamic platform dedicated to accelerating the advancement and deployment of affordable medical diagnostic technologies. It’s built on a robust network of partners, including innovators, manufacturers, startups, academic institutions, and both private and public sector organizations focused on market access.
The core aim? To deliver high-quality healthcare solutions that are affordable, available, and accessible to everyone. Ultimately, this translates to improved early diagnosis and better patient outcomes.
Cyient: A Decade of Dedication to MedTech
Founded in 1991, Cyient is a global leader in engineering and technology solutions. They partner with industry leaders across diverse sectors – from aerospace to energy – to drive innovation and value.
Over the past decade, Cyient has substantially expanded its presence in the medical technology space, and it’s now one of their fastest-growing industries. Their expertise is crucial in bringing complex diagnostic solutions to life.
India2022: A Business-Led vision for Growth
India2022 is a business-led coalition, conceptualized in 2016 and launched in 2017, focused on unlocking new growth opportunities within India.Powered by Xynteo, it brings together influential companies like Hindalco, Baker Hughes, Hindustan Unilever, Shell, State Bank of India, Tata Trusts, technipfmc, and WPP.
The coalition tackles pressing challenges through four key impact tracks: Waste to Value, Energize, Sustainable Mining, and Healthcare. The Healthcare track, led by Cyient, is specifically focused on expanding access to affordable diagnostics. This collaborative approach leverages the collective power of these organizations to drive meaningful change.
How This Collaboration Works: A Multi-Faceted Approach
This isn’t just about funding research. The 22 Coalition and India2022 are fostering a holistic ecosystem. Here’s how:
Catalyzing Innovation: Identifying and supporting promising diagnostic technologies.
Development & Manufacturing: facilitating the scaling of production for affordable solutions.
Startup Support: Providing mentorship and resources to emerging medtech companies.
Academic Partnerships: Leveraging research and expertise from leading institutions.
Market Access: Navigating regulatory hurdles and ensuring solutions reach those who need them most.
Meet the Expert: Dr. Vandana sarda
Leading the charge within the India2022 Healthcare Impact Track is Dr. Vandana Sarda, Principal at Cyient’s Mumbai office. With over 17 years of experience in healthcare, biotech, and pharmaceuticals, Dr. Sarda brings a wealth of knowledge to the table.
Her expertise spans commercial strategy,business development,and mentoring. She actively supports medtech startups at IIT-Bombay and Swissnex, and serves as an expert evaluator for BIRAC programs. Dr. Sarda’s dedication is instrumental in driving the coalition’s mission forward.
Stay Connected
Want to learn more or get involved? Here’s how:
Twitter: [email protected]
The 22 coalition, Cyient, and India2022 represent a powerful synergy. By fostering collaboration and focusing on affordability, they are paving the way for a future where quality diagnostics are accessible to all, ultimately improving health outcomes and transforming healthcare in India and beyond.
Keep reading